These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38116423)

  • 1. Discovery of Potent and Oral Bioavailable MAT2A Inhibitors for the Treatment of MTAP-Deleted Tumors.
    Li Q; Zang Y; An D; Liu L; Jiang W; Liu R; Su J; Yang J; Li L; Zhang X
    ACS Med Chem Lett; 2023 Dec; 14(12):1876-1881. PubMed ID: 38116423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic safety assessment via multi-omic characterisation of systemic pathway perturbations following in vivo MAT2A inhibition.
    Fogal V; Michopoulos F; Jarnuczak AF; Hamza GM; Harlfinger S; Davey P; Hulme H; Atkinson SJ; Gabrowski P; Cheung T; Grondine M; Hoover C; Rose J; Bray C; Foster AJ; Askin S; Majumder MM; Fitzpatrick P; Miele E; Macdonald R; Keun HC; Coen M
    Arch Toxicol; 2024 Aug; 98(8):2589-2603. PubMed ID: 38755480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration.
    Rodon J; Prenen H; Sacher A; Villalona-Calero M; Penel N; El Helali A; Rottey S; Yamamoto N; Ghiringhelli F; Goebeler ME; Doi T; Postel-Vinay S; Lin CC; Liu C; Chuang CH; Keyvanjah K; Eggert T; O'Neil BH
    Ann Oncol; 2024 Dec; 35(12):1138-1147. PubMed ID: 39293516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Surgical and Nonsurgical Aesthetic Procedures: A 14-Year Analysis of the International Society of Aesthetic Plastic Surgery-ISAPS.
    Triana L; Palacios Huatuco RM; Campilgio G; Liscano E
    Aesthetic Plast Surg; 2024 Oct; 48(20):4217-4227. PubMed ID: 39103642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Far Posterior Approach for Rib Fracture Fixation: Surgical Technique and Tips.
    Manes TJ; DeGenova DT; Taylor BC; Patel JN
    JBJS Essent Surg Tech; 2024; 14(4):. PubMed ID: 39650795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chicken meal is not an appropriate reference protein for estimating protein quality of ingredients used in extruded diets intended for dogs.
    Crosbie M; Templeman JR; Pezzali JG; Courtney-Martin G; Levesque CL; Hancock L; Buff PR; Columbus DA; Verbrugghe A; Shoveller AK
    J Anim Sci; 2024 Jan; 102():. PubMed ID: 39252579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020.
    de Groot TM; Ramsey D; Groot OQ; Fourman M; Karhade AV; Twining PK; Berner EA; Fenn BP; Collins AK; Raskin K; Lozano S; Newman E; Ferrone M; Doornberg JN; Schwab JH
    Clin Orthop Relat Res; 2023 Dec; 481(12):2419-2430. PubMed ID: 37229565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review.
    O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H
    Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.
    Christophersen OA
    Microb Ecol Health Dis; 2012; 23():. PubMed ID: 23990836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
    Sridhar S; Joaquin A; Bonaparte MI; Bueso A; Chabanon AL; Chen A; Chicz RM; Diemert D; Essink BJ; Fu B; Grunenberg NA; Janosczyk H; Keefer MC; Rivera M DM; Meng Y; Michael NL; Munsiff SS; Ogbuagu O; Raabe VN; Severance R; Rivas E; Romanyak N; Rouphael NG; Schuerman L; Sher LD; Walsh SR; White J; von Barbier D; de Bruyn G; Canter R; Grillet MH; Keshtkar-Jahromi M; Koutsoukos M; Lopez D; Masotti R; Mendoza S; Moreau C; Ceregido MA; Ramirez S; Said A; Tavares-Da-Silva F; Shi J; Tong T; Treanor J; Diazgranados CA; Savarino S
    Lancet Infect Dis; 2022 May; 22(5):636-648. PubMed ID: 35090638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the scientific knowledge and approaches to defining and measuring hate crime, hate speech, and hate incidents: A systematic review.
    Vergani M; Perry B; Freilich J; Chermak S; Scrivens R; Link R; Kleinsman D; Betts J; Iqbal M
    Campbell Syst Rev; 2024 Jun; 20(2):e1397. PubMed ID: 38686101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors.
    Elsayed MSA; Blake JF; Boys ML; Brown E; Chapsal BD; Chicarelli MJ; Cook AW; Fell JB; Fischer JP; Hanson L; Lemieux C; Martinson MC; McCown J; McNulty OT; Mejia MJ; Neitzel NA; Otten JN; Rodriguez ME; Wilcox D; Wong CE; Zhou Y; Hinklin RJ
    ACS Med Chem Lett; 2023 Dec; 14(12):1673-1681. PubMed ID: 38116446
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.